Cortical blindness and seizures in a patient receiving FK506 after bone marrow transplantation

Bone Marrow Transplantation

Volumn 23, Issue 9, 1999, Pages 959-962

  Steg, R E ^b   Kessinger, A ^a   Wszolek, Z K ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone marrow transplantation; Cortical blindness and seizures; FK506 neurotoxicity

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CEREBRAL BLINDNESS; DRUG WITHDRAWAL; DYSPNEA; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MYELODYSPLASTIC SYNDROME; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN SATURATION; PRIORITY JOURNAL; SEIZURE; WHEEZING; WHITE MATTER;

EID: 0032910099     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701732     Document Type: Article

References (10)

1. Neuberger J, Elias E. Immunosuppressive agents. In: Maddrey WC, Sorrell MF (eds). Transplantation of the Liver, 2nd edn. Appleton and Lange: Norwalk, 1995, pp 247-265.
2. Rubin AM, Kang H. Cerebral blindness and encephalopathy with cyclosporin A toxicity. Neurology 1987; 37: 1072-1076.
3. De Groen PC, Aksamit AJ, Rakela J et al. Central nervous system toxicity after liver transplantation. New Engl J Med 1987; 317: 861-866.
4. Lane RJM, Roche SE, Leung AAW et al. Cyclosporine neurotoxicity in cardiac transplant recipients. J Neurol Neurosurg Psychiat 1988; 51: 1434-1437.
5. Rubin AM. Transient cortical blindness and occipital seizures with cyclosporine toxicity. Transplantation 1989; 47: 572-573.
6. Scheinman SJ, Reinitz ER, Petro G et al. Cyclosponne central neurotoxicity following renal transplantation. Transplantation 1990; 49: 215-216.
7. Casanova B, Prieto M, Deye E et al. Persistent cortical blindness after cyclosporine leukoencephalopathy. Liver Transplant Surg 1997; 3: 638-640.
8. Shutter LA, Green JP, Newman NJ et al. Cortical blindness and white matter lesions in a patient receiving FK506 after liver transplantation. Neurology 1993; 43: 2417-2418.
9. Devine SM, Newman NJ, Siegel JL et al. Tacrolimus (FK506)-induced cerebral blindness following bone marrow transplantation. Bone Marrow Transplant 1996; 18: 569-572.
10. Eidelman BH, Abu-Elmagd K, Wilson J et al. Neurologic complications of FK506. Transplant Proc 1991; 23: 3175-3178.